Neo Karnim

Nagpur, India Founded: 2023 • Age: 3 yrs
Herbal capsules for controlling blood sugar and supporting diabetes care.

About Neo Karnim

Neo Karnim is a Healthcare company based in Nagpur (India) founded in 2023. Herbal capsules for controlling blood sugar and supporting diabetes care. It operates on a D2C and B2C model. The company has 76 employees. Its Indian entity Unijules Life Sciences Limited reported revenue of β‚Ή61.64 Cr. Neo Karnim offers products and services including Neo Karnim Capsules and Neo Karnim Treatment Packs. Its focus areas include Wellness Tech, Supplements, Diabetes Management and Herbal Medicine.

Company details

Neo Karnim is a herbal supplement designed to manage diabetes by controlling blood sugar levels and reducing related complications. It uses natural ingredients like karela and neem to support heart health and overall well-being. Manufactured in Nagpur, India, it is available through online sales and chemists, serving individuals with diabetes or at risk.

  • Headquarters Nagpur, India
  • Employees 76
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website neokarnim.com
  • Social Instagram
  • Legal Name Unijules Life Sciences Ltd.
  • Date of Incorporation 16 Jan, 2006
  • Jurisdiction Nagpur, Maharashtra, India
Operational Areas
Key Metrics
  • Annual Revenue
    ₹61.64 Cr

    FY 2018 · -4% YoY

  • Net Loss
    -₹10.68 Cr

    FY 2018 · -17% margin

  • EBITDA
    ₹3.69 Cr

    FY 2018 · 6% margin

  • Employee Count
    76

Products & Services of Neo Karnim

Neo Karnim offers a comprehensive portfolio of products and services, including Neo Karnim Capsules and Neo Karnim Treatment Packs.

Neo Karnim Capsules
Herbal Supplement

Capsules for managing diabetes and improving blood sugar levels.

Neo Karnim Treatment Packs
Health Package

Multi-capsule packs for extended diabetes support and wellness.

Board of directors of Unijules Life Sciences Limited (Neo Karnim)

Unijules Life Sciences Limited is the primary company behind Neo Karnim. The board of Unijules Life Sciences Limited currently have 3 directors; the longest-serving is Pawan Kumar Chokhani, appointed in 2026. 26 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pawan Kumar Chokhani
DIN 00550963
Director01 Jan 202610 moUnijules Life Sciences Limited
Pranav Pawan Chokhani
DIN 07259400
Director01 Jan 202610 moUnijules Life Sciences Limited
Ankit Pawan Chokhani
DIN 05208727
Director01 Jan 202610 moUnijules Life Sciences Limited

Financials of Neo Karnim

Figures of Unijules Life Sciences Limited, the primary company behind Neo Karnim, for FY 2018. Revenue was ₹61.64 Cr (-4% year on year). Net loss was -₹10.68 Cr (-17% margin). EBITDA was ₹3.69 Cr (6% margin). Revenue has grown at a compounded annual rate of -4% over three years.

  • ₹61.64 CrRevenue · FY 2018 · -4% YoY
  • -₹10.68 CrNet loss · -17% margin
  • ₹3.69 CrEBITDA · 6% margin
  • ₹1.00 CrPaid-up capital
  • 57Employees (provident fund records)
  • -4%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Unijules Life Sciences Limited are on its company page.

Premium access

Detailed financial statements for Neo Karnim

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Neo Karnim

Neo Karnim was founded in 2023.

Neo Karnim is headquartered in Nagpur, India. It is registered at Nagpur, Maharashtra, India.

Neo Karnim has 76 employees.

The primary company behind Neo Karnim, Unijules Life Sciences Limited, reported revenue of β‚Ή61.64 Cr for FY 2018, down 4% year on year.

Neo Karnim is a herbal supplement designed to manage diabetes by controlling blood sugar levels and reducing related complications. It uses natural ingredients like karela and neem to support heart health and overall well-being. Manufactured in Nagpur, India, it is available through online sales and chemists, serving individuals with diabetes or at risk.

Neo Karnim offers Neo Karnim Capsules and Neo Karnim Treatment Packs.

Neo Karnim operates through Unijules Life Sciences Limited.

The legal entities of Neo Karnim currently have 3 directors, including Pawan Kumar Chokhani, Pranav Pawan Chokhani, Ankit Pawan Chokhani.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available